华纳药厂：子公司通过巴西国家卫生监督局GMP认证

Core Viewpoint - Warner Pharmaceuticals (688799.SH) announced that its wholly-owned subsidiary, Hunan Warner Pharmaceutical Co., Ltd., received the Good Manufacturing Practice (GMP) certification from Brazil's National Health Surveillance Agency, allowing the company to enter the Brazilian market with its chemical raw material drug, Phosphomycin Amino Butanol, which is valid until January 19, 2028 [1] Group 1 - The GMP certification enhances the company's international competitiveness by facilitating market entry in Brazil [1] - The certification specifically pertains to the production of Phosphomycin Amino Butanol, a chemical raw material drug [1] - The effective period of the GMP certification is until January 19, 2028 [1] Group 2 - The international raw material drug business in the pharmaceutical industry is subject to uncertainties due to national policies and changes in the overseas market environment [1]